Leonard Kalman
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 10%
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Co-authors
- Mark G. KrisJohn D. HainsworthJeffrey CrawfordVincent A. MillerF. GamzaDaniel D. KarpJin Soo LeeLuz Hammershaimb
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Lung Cancer Research Studies (8 papers)Cancer Treatment and Pharmacology (5 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Leonard Kalman
28 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 1.3k
- Surgery 355
- Molecular Biology 305
- Pathology and Forensic Medicine 216
Countries citing papers authored by Leonard Kalman
This map shows the geographic impact of Leonard Kalman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard Kalman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard Kalman more than expected).
Fields of papers citing papers by Leonard Kalman
This network shows the impact of papers produced by Leonard Kalman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard Kalman. The network helps show where Leonard Kalman may publish in the future.
Co-authorship network of co-authors of Leonard Kalman
This figure shows the co-authorship network connecting the top 25 collaborators of Leonard Kalman. A scholar is included among the top collaborators of Leonard Kalman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard Kalman. Leonard Kalman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 2 | |
| 3 | 40 | |
| 4 | 2 | |
| 5 | 92 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 7 | |
| 9 | 132 | |
| 10 | 59 | |
| 11 | Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer. | 12 |
| 12 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimensbreakdown → | 1124 |
| 13 | 35 | |
| 14 | 97 | |
| 15 | 70 | |
| 16 | 24 | |
| 17 | 3 | |
| 18 | High Dose Chemotherapy with Peripheral Blood Stem Cell Support for High Risk Stage II and Stage III Breast Cancer | 5 |
| 19 | 70 | |
| 20 | 154 |
About Leonard Kalman
Leonard Kalman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Oral Surgery, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (1.5k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Cancer Research (212 citations). Leonard Kalman has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Mark G. Kris, John D. Hainsworth, Jeffrey Crawford, Vincent A. Miller, F. Gamza, Daniel D. Karp, Jin Soo Lee, Luz Hammershaimb, Everett E. Vokes and Frank V. Fossella. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.